Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1998 May;64(5) > Minerva Anestesiologica 1998 May;64(5):257-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

Vth SECTION
SAH-PATIENTS OUTCOME, COMPLICATIONS AND PREVENTION, FUTURE PROSPECTS  PROCEEDINGS OF THE VIDEOCONFERENCE - October 5, 1996
SUBARACHNOID HEMORRHAGE: A MULTIDISCIPLINARY APPROACH - II
 Freefree

Minerva Anestesiologica 1998 May;64(5):257-9

Copyright © 1998 EDIZIONI MINERVA MEDICA

language: Italian

Future prospects of pharmachological SAH treatment

Carteri A., Billeci D., Copetti E.

Ospedale Regionale «Ca’ Foncello» - Treviso, Divisione Clinicizzata di Neurochirurgia


PDF


The aim of pharmacological therapy in sub-arachnoid haemorrhage (SAH) is to prevent cerebral ischemia and consequent events. Vasospasm, energy decrease, alterated Ca++ homeostasis, lactic acidosis and free radicals are responsibles for cerebral ischemic damage. Drug therapy in SAH is necessary before, during and after surgical treatment. Nimodipine is the only drug used today and supported by many clinical trials; scientific trials, on using known and new substances in SAH drug therapy, are in progress.

top of page